About DURECT
Vision
History
Patient Focus
Management
Board of Directors
Corporate Policies/Governance
   Board Committee Charters   
   Code of Ethics   
   Whistleblower Policy   
   Corporate Governance Guidelines   
Contact DURECT
Driving Directions

Products
Development Pipeline
   POSIDUR™   
   TRANSDUR®-Sufentanil   
   Remoxy®   
   ELADUR® (TRANSDUR®-Bupivacaine)   
   ORADUR®-ADHD Program   
   Relday™   
Commercial Products
   ALZET®   
   LACTEL®   
Research Programs
   Product Candidates   
   Asthma   

Business Development
Business Development Approach

Science & Technologies
The SABER® and Cloud™ Injectable Depot Systems
ORADUR® Oral Delivery System
TRANSDUR® Transdermal Technology System
DURIN® System
Localized Drug Delivery
Patents
Publications

Search Contact Legal Notice
Investor Relations
Stock Information
Corporate Presentation
Financial News
Earnings Estimate
Media Kit
   Fact Sheets   
   Logos and Graphics   
   Logos   
   Press Contacts   
Analyst Coverage
Financial Reports
SEC Filings
Event Calendar
FAQs
E-mail Alerts
Information Request

Careers
Benefits Overview
Job Openings
Attention Recruiters

News



 © 2000-2014 DURECT Corporation
Last updated: April 07, 2014